Testing menstrual blood for human papillomavirus (HPV) could be a "robust alternative or replacement" for current cervical ...

About 70 per cent of cases are prevented through cervical screening, according to cancer research, and the HPV vaccine is ...

Pap smears and HPV tests can catch issues early—long before they become cancer. Learn why these simple screenings matter and how to make the experience more comfortable.

A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

Medicare Part B generally covers HPV tests every five years for individuals ages 30–65 without symptoms, as part of a Pap test. Individuals over 65 may not need regular HPV testing if previous results ...

Women who have been vaccinated against human papillomavirus (HPV) should be screened for cervical cancer less often, a study has suggested.1 For women vaccinated at young ages, screening just two or ...

However, the test for antibodies against HPV16 E6 is not suitable for assessing the risk for cervical cancer and other HPV-associated cancers in genital areas. As opposed to cancer of the oropharynx, ...

Outcomes in HPV-associated oropharyngeal squamous cell carcinoma after postoperative or definitive nonsurgical therapy. Background: Human papillomavirus (HPV) type 16 is associated with a subset of ...